<?xml version="1.0" encoding="UTF-8"?>
<p id="p0245">Danoprevir is an NS3/4A protease inhibitor that is used as an anti-HCV drug. It interferes with virus replication and suppresses the effects of the virus on the host response to viral infection. In a small clinical trial of 11 COVID-19 patients, after 4 to 12Â days of use of Danoprevir, all the patients recovered 
 <xref rid="b0470" ref-type="bibr">[94]</xref>. So, it might be suggested that Danoprevir could be effective against SARS-CoV-2.
</p>
